A detailed history of Bokf, Na transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Bokf, Na holds 2,232 shares of TEVA stock, worth $39,885. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,232
Previous 2,232 -0.0%
Holding current value
$39,885
Previous $31,000 16.13%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$10.67 - $14.43 $8,568 - $11,587
-803 Reduced 26.46%
2,232 $31,000
Q3 2023

Nov 14, 2023

BUY
$7.48 - $10.7 $5,692 - $8,142
761 Added 33.47%
3,035 $30,000
Q2 2023

Aug 21, 2023

BUY
$7.2 - $9.47 $14,400 - $18,940
2,000 Added 729.93%
2,274 $17,000
Q1 2023

May 11, 2023

BUY
$8.36 - $11.37 $2,290 - $3,115
274 New
274 $2,000
Q2 2019

Aug 14, 2019

SELL
$8.12 - $15.72 $98,365 - $190,432
-12,114 Closed
0 $0
Q1 2019

May 15, 2019

SELL
$15.58 - $20.01 $53,875 - $69,194
-3,458 Reduced 22.21%
12,114 $190,000
Q4 2018

Feb 13, 2019

SELL
$14.59 - $23.84 $71,388 - $116,649
-4,893 Reduced 23.91%
15,572 $240,000
Q3 2018

Nov 13, 2018

SELL
$21.06 - $25.65 $19,901 - $24,239
-945 Reduced 4.41%
20,465 $441,000
Q2 2018

Aug 13, 2018

BUY
$16.77 - $24.71 $27,335 - $40,277
1,630 Added 8.24%
21,410 $520,000
Q1 2018

May 14, 2018

SELL
$16.68 - $22.07 $350,697 - $464,021
-21,025 Reduced 51.53%
19,780 $338,000
Q4 2017

Feb 14, 2018

BUY
$11.23 - $19.1 $211,225 - $359,251
18,809 Added 85.51%
40,805 $773,000
Q3 2017

Nov 14, 2017

BUY
$15.41 - $32.17 $33,254 - $69,422
2,158 Added 10.88%
21,996 $387,000
Q2 2017

Aug 14, 2017

BUY
N/A
19,838
19,838 $659,000

Others Institutions Holding TEVA

About TEVA PHARMACEUTICAL INDUSTRIES LTD


  • Ticker TEVA
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,110,560,000
  • Market Cap $19.8B
  • Description
  • Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...
More about TEVA
Track This Portfolio

Track Bokf, Na Portfolio

Follow Bokf, Na and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bokf, Na, based on Form 13F filings with the SEC.

News

Stay updated on Bokf, Na with notifications on news.